Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy
Simple Summary
Lim, C.H.; Park, S.B.; Kim, H.K.; Choi, Y.S.; Kim, J.; Ahn, Y.C.; Ahn, M.-j.; Choi, J.Y. Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy. Cancers 2022, 14, 632. https://doi.org/10.3390/cancers14030632
Lim CH, Park SB, Kim HK, Choi YS, Kim J, Ahn YC, Ahn M-j, Choi JY. Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy. Cancers. 2022; 14(3):632. https://doi.org/10.3390/cancers14030632
Chicago/Turabian StyleLim, Chae Hong, Soo Bin Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Yong Chan Ahn, Myung-ju Ahn, and Joon Young Choi. 2022. "Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy" Cancers 14, no. 3: 632. https://doi.org/10.3390/cancers14030632